RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Showing results 1 to 20 of 54.

Expert

Elliott Pauli

Event

RTI Fellow Program Distinguished Lecture Series: Doris Rouse presents Public-Private Partnerships to Advance Medical Product Development

January 30, 2023
News Release

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

August 14, 2019
Expert

Diana Severynse-Stevens

Event

Southeast Regional Meeting of the American Chemical Society 2023 Annual Meeting

October 25, 2023
Impact

Ulipristal Acetate

April 11, 2016
Focus Area

Cannabis Research

Focus Area

Preventing Substance Use

RTI In The Media

FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB

August 15, 2019 - Medscape
Insight

READDI Forethought uses the power of collaboration to accelerate scientific discovery

October 11, 2022
Expert

Sharon Daily

RTI In The Media

RTP-Based APIE Therapeutics, RTI Team Up to Develop Drug for Rare Lung Disease

August 26, 2020 - WRAL TechWire
News Release

RTI International Licenses Portfolio of Compounds to APIE Therapeutics

August 25, 2020
Announcement

In Memoriam: Mansukh Wani

April 16, 2020
Impact

Novel Solutions: The Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB)

September 26, 2022
Impact

Long-Acting Implantable HIV Prevention

February 21, 2018
Expert

Sara Maloney Norcross

Expert

Nathan Vandergrift

Impact

New Drug Approved for Treatment of Extensively Drug-Resistant Tuberculosis

July 02, 2019
RTI In The Media

Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators

August 14, 2019 - The Telegraph